Colgate-Palmolive: Barclays Keeps Equal-Weight Rating, PT Down to $82
PorAinvest
miércoles, 1 de octubre de 2025, 11:23 am ET1 min de lectura
BCS--
Colgate-Palmolive reported earnings of $0.92 per share for the last quarter, surpassing analysts' expectations of $0.89, with revenue of $5.11 billion. The company also announced a quarterly dividend of $0.52 per share, to be paid on November 14th, representing an annualized yield of 2.6% [1].
The company's stock has seen increased interest from institutional investors and hedge funds. HB Wealth Management LLC, for instance, increased its stake by 7.1%, owning 81,142 shares worth approximately $7.37 million following the purchase of an additional 5,370 shares [1]. Several other hedge funds have also made significant changes to their positions in Colgate-Palmolive, with Westend Capital Management LLC raising its position by 111.1% and Cornerstone Planning Group LLC by 1,913.3% during the first quarter [1].
Analysts have mixed opinions on the stock. Wells Fargo & Company, JPMorgan Chase & Co., Morgan Stanley, and Citigroup have all revised their target prices, with Wells Fargo lowering its target to $80.00 and setting an underweight rating. Meanwhile, Barclays increased its price objective to $87.00 before lowering it to $82.00, maintaining an equal-weight rating [1].
Colgate-Palmolive has a market capitalization of $64.66 billion, a PE ratio of 22.47, and a price-to-earnings-growth ratio of 4.18. The company's stock has a beta of 0.35, indicating a lower volatility compared to the broader market [1].
As of September 12, 2025, Colgate-Palmolive's stock has been trading at $80.00, with a 50-day moving average of $83.89 and a 200-day moving average of $88.56. The company's debt-to-equity ratio is 6.79, and its current ratio is 0.89, indicating a solid financial position [1].
CL--
Colgate-Palmolive: Barclays Keeps Equal-Weight Rating, PT Down to $82
Barclays has maintained its equal-weight rating for Colgate-Palmolive (NYSE:CL) but has lowered its price target to $82. The investment bank's latest research report reflects the company's recent financial performance and market conditions [1].Colgate-Palmolive reported earnings of $0.92 per share for the last quarter, surpassing analysts' expectations of $0.89, with revenue of $5.11 billion. The company also announced a quarterly dividend of $0.52 per share, to be paid on November 14th, representing an annualized yield of 2.6% [1].
The company's stock has seen increased interest from institutional investors and hedge funds. HB Wealth Management LLC, for instance, increased its stake by 7.1%, owning 81,142 shares worth approximately $7.37 million following the purchase of an additional 5,370 shares [1]. Several other hedge funds have also made significant changes to their positions in Colgate-Palmolive, with Westend Capital Management LLC raising its position by 111.1% and Cornerstone Planning Group LLC by 1,913.3% during the first quarter [1].
Analysts have mixed opinions on the stock. Wells Fargo & Company, JPMorgan Chase & Co., Morgan Stanley, and Citigroup have all revised their target prices, with Wells Fargo lowering its target to $80.00 and setting an underweight rating. Meanwhile, Barclays increased its price objective to $87.00 before lowering it to $82.00, maintaining an equal-weight rating [1].
Colgate-Palmolive has a market capitalization of $64.66 billion, a PE ratio of 22.47, and a price-to-earnings-growth ratio of 4.18. The company's stock has a beta of 0.35, indicating a lower volatility compared to the broader market [1].
As of September 12, 2025, Colgate-Palmolive's stock has been trading at $80.00, with a 50-day moving average of $83.89 and a 200-day moving average of $88.56. The company's debt-to-equity ratio is 6.79, and its current ratio is 0.89, indicating a solid financial position [1].
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
Comentarios
Aún no hay comentarios